PHENAZO TABLET

国: カナダ

言語: 英語

ソース: Health Canada

有効成分:

PHENAZOPYRIDINE HYDROCHLORIDE

から入手可能:

BAUSCH HEALTH, CANADA INC.

ATCコード:

G04BX06

INN（国際名）:

PHENAZOPYRIDINE

投薬量:

100MG

医薬品形態:

TABLET

構図:

PHENAZOPYRIDINE HYDROCHLORIDE 100MG

投与経路:

ORAL

パッケージ内のユニット:

250ML

処方タイプ:

Prescription

治療領域:

ANTIPRURITICS AND LOCAL ANESTHETICS

製品概要:

Active ingredient group (AIG) number: 0106949001; AHFS:

認証ステータス:

APPROVED

承認日:

2004-09-08

製品の特徴

PRESCRIBING INFORMATION
PR
PHENAZO
®
Phenazopyridine Hydrochloride Tablets
100 mg and 200 mg Tablets
URINARY ANALGESIC
BAUSCH HEALTH, CANADA INC.
DATE OF REVISION:
2150 St-Elzear Blvd. West
November 20, 2020
Laval, Quebec
H7L 4A8
Control No.: 245653

_ _
_ _
_Pr_
_PHENAZO _
_®_
_ Prescribing Information Page 2 of 16_
TABLE OF CONTENT
PART I: HEALTH PROFESSIONAL INFORMATION
.......................................................... 3
SUMMARY PRODUCT INFORMATION
.........................................................................
3
INDICATIONS AND CLINICAL USE
...............................................................................
3
CONTRAINDICATIONS
....................................................................................................
4
WARNINGS AND PRECAUTIONS
..................................................................................
4
ADVERSE REACTIONS
....................................................................................................
6
DRUG INTERACTIONS
.....................................................................................................
6
DOSAGE AND ADMINISTRATION
.................................................................................
7
OVERDOSAGE
...................................................................................................................
7
ACTION AND CLINICAL PHARMACOLOGY
............................................................... 8
STORAGE AND STABILITY
............................................................................................
8
DOSAGE FORMS, COMPOSITION AND PACKAGING
................................................ 8
PART II: SCIENTIFIC INFORMATION
.................................................................................
10
PHARMACEUTICAL INFORMATION
..........................................................................
10
DETAILED PHARMACOLOGY
......................................................................................
11
TOXICOLOGY
..........................